ArticleAsian journal of transfusion science
Coronavirus disease-2019 pandemic: Maintaining an adequate and safe supply of blood and blood products.
Article in Asian journal of transfusion science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The coronavirus disease-2019 (COVID-19) pandemic has influenced all the dimensions of human lives and the functional pattern of the health care establishments as the caseload continues to rise at an alarming speed. Even though, the possibility of transmission of infection through blood is negligible, it is important to take into account that the ongoing pandemic is going to impact the supply of blood and blood products via reduction in the practice of voluntary blood donation, and the entire range of activities pertaining to the blood system. This calls for the need to assess the situation, plan for remedial measures and respond adequately to the existing problem. In conclusion, in the battle against the COVID-19 infection, it is of utmost importance that the supply of blood and its products needs to be continually maintained, and the most effective approach will be to integrate the various elements of the blood system within the public health care delivery system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.